SNDX earnings
Syndax Pharmaceuticals (SNDX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
SNDX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | -0.55 | -0.45 | -22.86% | $72.79M |
| Q1 2026 | Apr 30, 2026 | -0.48 | -0.59 | 18.64% | $64.86M |
| Q4 2025 | Feb 26, 2026 | -0.78 | -0.58 | -33.55% | $68.48M |
| Q3 2025 | Nov 3, 2025 | -0.70 | -0.74 | 5.41% | $45.87M |
| Q2 2025 | Aug 4, 2025 | -0.83 | -1.00 | 17.00% | $37.96M |
| Q1 2025 | May 5, 2025 | -0.98 | -1.04 | 5.77% | $20.04M |
| Q4 2024 | Mar 3, 2025 | -1.10 | -1.08 | -1.85% | $7.68M |
| Q3 2024 | Nov 5, 2024 | -0.98 | -1.13 | 13.27% | $12.50M |
| Q2 2024 | Aug 1, 2024 | -0.80 | -0.91 | 12.09% | $3.50M |
| Q1 2024 | May 8, 2024 | -0.85 | -0.96 | 11.46% | – |
| Q4 2023 | Feb 27, 2024 | -1.00 | -0.99 | -1.01% | – |
| Q3 2023 | Nov 2, 2023 | -0.73 | -0.80 | 8.75% | – |
| Aug 3, 2023 | -0.64 | -0.73 | 12.33% | – | |
| May 8, 2023 | -0.59 | -0.61 | 3.28% | – | |
| Feb 28, 2023 | -0.62 | -0.64 | 3.13% | – | |
| Nov 3, 2022 | -0.58 | -0.65 | 10.77% | – | |
| Aug 8, 2022 | -0.62 | -0.65 | 4.62% | – | |
| May 9, 2022 | -0.63 | -0.63 | 0.00% | – | |
| Mar 1, 2022 | 1.81 | 0.28 | 546.43% | – | |
| Nov 15, 2021 | -0.40 | -0.64 | 37.50% | – |
- SNDX beat EPS estimates in 31 of its last 42 reports.
Updated 2026-11-03 01:58 UTC